All I really know is what I read and it looks like that patent is not going to interfere with $MRNA
development. If it turns out to be a problem MRNA will either pay them off or buy the company in its entirety. ABUS is worth only $425M
(after recently doubling in price) while MRNA is worth $29B
. Nothing is going to stop MRNA except an ineffective drug. That’s why I’m in MRNA and also trading in INO and NVAX, among others.